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ABSTRACT
ShortinterferingRNAs(siRNAs)areapopularmethod
for gene-knockdown, acting by degrading the target
mRNA.Beforeperformingexperimentsitisinvaluable
to locate and evaluate previous knockdown experi-
ments for the gene of interest. The siRNA database
provides a gene-centric view of siRNA experimental
data, includingsiRNAsofknown efficacy andsiRNAs
predicted to be of high efficacy by a combination of
methods. Linked to these sequences is information
such as siRNA thermodynamic properties and the
potential for sequence-specific off-target effects.
The database enables the user to evaluate an
siRNA’s potential for inhibition and non-specific
effects. The database is available at http://
siRNA.cgb.ki.se.
INTRODUCTION
Short interfering RNAs (siRNAs) enable the inhibition of
single genes at the nucleotide level. They are duplexes of
two RNA molecules, typically 21mers with a 2 nt 30 overhang
(1). A particular strength of this method of knockdown is that
an siRNA can be designed to inhibit the expression of any
mRNA, and thus the protein it encodes. The knockdown
approach, unlike a knockout, allows detailed study of the
effects of reducing a gene’s expression to none for a period
of time, and then allowing its expression to return to normal.
This effect can be demonstrated without affecting related pro-
teins, making it an invaluable tool for functional genomics.
siRNAs have been found to be effective in Arabidopsis
thaliana, Drosophila melanogaster, Caenorhabditis elegans
and mammals (2). For an in-depth review of the subject see
e.g. (2,3).
With the increased utilization of siRNAs it is essential to
keep track of siRNAs that have been published. Experimen-
talists wish to easily be able to ﬁnd siRNAs that have already
been veriﬁed for their target gene. If such siRNAs exist, the
researcher will be interested in the conditions under which
the siRNA was tested, and the reference to the article
where the siRNA was published for further investigation. If
no such siRNAs exist then the researcher probably wants to
choose an siRNA designed using one of a number of recently
published methods (4–8). In both cases it is important to
identify potential sequence-speciﬁc off-target effects of the
siRNA. An additional user group for an siRNA database con-
sists of bioinformaticians. In this case the primary interest is
the underlying data, which can be downloaded for subsequent
analysis and the building of predictive models.
THE DATABASE
Contents
The database contains information about siRNA molecules
from two sources: (i) siRNAs collected from the literature
that have experimentally veriﬁed efﬁcacy and (ii) siRNAs
selected computationally to target the REFSEQ (9) curated
human gene set (20410 ‘NM’ sequences and 6767 ‘XM’
sequences). The database holds experimental information
gathered from literature for siRNAs in set (i). This includes
efﬁcacy, cell type, efﬁcacy assay and information about the
target gene. When exact ﬁgures for efﬁcacy are unavailable we
approximate the value; these values are marked with a type
(validated, predicted, approximated or generalized) to indicate
the method used to determine the efﬁcacy value. Detailed
descriptions of these types are available online.
For genes with no experimentally veriﬁed siRNA in the
database, we provide a set of predictions using the following
combination of prediction methods. siRNAs were selected
only if the siSearch (6) score exceeded 5, the Reynolds
(10) score exceeded 5, and the Ui-tei (11) score was Ia or
Ib. This set of predicted siRNAs was then subjected to a
BLAST speciﬁcity search against the REFSEQ database,
and siRNAs were retained only if they had no matches to
other genes (16 or more consecutive bases).
A link to PubMed with a pre-formulated siRNA query
search is also made available to allow the user to easily
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In release 1.0 there are 500 experimentally veriﬁed siRNAs
targeting 115 genes. These data were gathered from 55 arti-
cles. Since siRNAs are being continuously added to the data-
base in an ongoing manner we recommend checking the server
for the latest release information. The distribution of siRNAs
per gene is not ﬂat; some genes have a large number of data
points, while many contain only a few. The distribution of
the efﬁcacies of the siRNAs is shown in Figure 1. Of the
500 siRNAs, 12.8% give knockdown efﬁcacy >90% while
55.8% give efﬁcacy >50%. The experiments use either nucleo-
tide or protein expression levels to measure efﬁcacy; 297 use
nucleotide and 198 use protein levels. A number of different
transfection reagents were used, with lipofectamine 2000
being the most commonly used (70% of cases) reagent. A
total of 109001 siRNAs (from 21075 genes) matched the
prediction criteria speciﬁed in the previous section. Of
those, 42155 siRNAs from 12888 genes were also found to
be speciﬁc using BLAST criteria; 14189 genes have no
siRNAs matching these criteria, owing to the strict require-
ments for the automated predictions. If siRNAdb lacks
predictions for a gene it is recommended that the user
manually search for siRNA sequences using one, or a combi-
nation of siRNA prediction servers.
The database interface
The database interface was designed with the experimental
user group as the primary target audience. The user interface
is gene-centric, allowing the user to search by nucleotide
accession number, free text, sequence or by viewing the list
of genes with veriﬁed siRNAs.
The layout of the database is straightforward and requires
onlybriefdescription. Foreach gene asummaryofthesiRNAs
are shown with links to more detailed information (see
Figure 2). The following list illustrates the organization of
the data as viewed within siRNAdb. Click on the links
below to open the relevant help pages with more verbose
documentation than is required here.
  Searching the database
  A gene record
  Individual siRNA records
  Data specific to verified siRNA
  Data specific to predicted siRNA
  Comparison of search methods (AOsearch, BLAST)
  Definitions
  Submit siRNA data to our database
  Downloading the database
siRNA calculations
A multitude of factors have been identiﬁed as being important
for governing siRNA efﬁcacy. We calculate and display these
factors. Summary statistics are self-evident, and energy pro-
ﬁles are described in (6). The energy data displayed includes
the ‘start’ and ‘end’ energies, representing the strength of
binding at each end of the siRNA.
Implementation
The database is implemented in MySQL version 4. The central
table in the database is called siRNA, and contains information
about the siRNA such as sense and antisense sequences, over-
hangs and target sequence. The second most important table in
the database is the Experiment table that contains a list of all
experiments performed on the siRNAs as well as references to
PubMed. Efﬁcacies for an experiment are stored either as
‘validated’ or ‘predicted’ to distinguish these types. Each
siRNA can have multiple experiments attached to them, as
several experiments can be performed using the same siRNA
sequence.
The querying of the underlying SQL database is imple-
mented using Java servlets running on an Apache Tomcat
server.
Figure 1. Efficacy level distribution in siRNAdb.
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Figure2.ViewofHumanAKT1siRNAdata.(a)Geneviewand(b)energyprofilesforasinglesiRNA.Thefirstcurveshowsdi-nucleotidebindingenergyvalues,as
calculated using the method of Mathews et al. (14). The straight horizontal lines represent the binding energy at each end as calculated by Schwarz et al. (15). The
secondsetofcurvesrepresentsfreeenergyprofilescalculatedusingthemethodofKhvorovaetal.(16).TheblackcurveisthatofthecurrentsiRNA.Theadditional
greenandredcurvesaretheaveragedreferencevaluesforbestandworstsiRNAs,respectively.Allcurvesarecalculatedfromantisense50 !30,whichisright!left
in this display.
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Non-speciﬁc off-target effects caused by siRNAs matching
genes other than their intended target gene render experimen-
tal results hard to interpret or useless. It is essential that
siRNAs are designed correctly to take this problem into
account. We use two methods for calculating potential
sequence-speciﬁc off-target effects. For experimentally
veriﬁed siRNAs we search using AOsearch (http://
aosearch.cgb.ki.se) to look for hits with 0–2 mismatches, com-
bined with BLAST. AOsearch uses inexact pattern matching
with AGREP (12) that is more sensitive than BLAST for short
sequence searches with mismatches. For predicted siRNAs
searching with AOsearch is too computationally expensive,
hence we used BLAST to identify matches with 16 bp in
common. We hope to have AOsearch results incorporated
into the server soon, however. For a comparison of exact
matching methods versus BLAST (13).
Quality control
We only collect data from other sources and we do not attempt
to evaluate the entries ourselves. It is assumed that the experi-
mental veriﬁcation claimed by the authors of siRNA experi-
ments is correct, and that suitable controls were used to ensure
this. By displaying limited experimental information and pro-
viding a link to the source article, we provide the user with
resources to evaluate the quality of the siRNA.
Submission
In order to maintain an up-to-date resource we encourage
experimentalists to submit their siRNA data directly to us
as soon as their paper is published. We accept user submis-
sions of siRNA sequences or publications via email. Such
submissions are manually checked before addition to the
database.
CONCLUSIONS/FUTURE PERSPECTIVES
The database is a collection of siRNA experiments. It was
designed to assist experimentalists in determining which
siRNA to use to inhibit their gene of interest. As more siRNAs
are veriﬁed this database will become increasingly useful for
developing siRNA design tools. One future plan is to complete
a genome-wide siRNA set for the mouse; where human–
mouse orthologs are identical, the same siRNA may be
used to target both genes. The database was designed to
hold results from a number of different prediction methods,
and we invite siRNA prediction groups to submit their pre-
dictions to the database.
AVAILABILITY
The database implementation and veriﬁed siRNAs are avail-
able at http://siRNA.cgb.ki.se for non-commercial use. The
experimentally veriﬁed section of the database is available
for download. For-proﬁt organizations are requested to contact
the corresponding author.
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